nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—Promazine—Tamoxifen—pancreatic cancer	0.518	1	CrCrCtD
Mesoridazine—KCNH2—Sunitinib—pancreatic cancer	0.0855	0.512	CbGbCtD
Mesoridazine—CYP2D6—Tamoxifen—pancreatic cancer	0.0359	0.215	CbGbCtD
Mesoridazine—CYP2D6—Erlotinib—pancreatic cancer	0.0305	0.183	CbGbCtD
Mesoridazine—CYP2D6—Doxorubicin—pancreatic cancer	0.0151	0.0902	CbGbCtD
Mesoridazine—HTR2C—Signaling Pathways—EGF—pancreatic cancer	3.53e-05	0.000112	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HIF1A—pancreatic cancer	3.52e-05	0.000112	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	3.51e-05	0.000111	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TSC2—pancreatic cancer	3.51e-05	0.000111	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	3.5e-05	0.000111	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—APOE—pancreatic cancer	3.49e-05	0.000111	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—STK11—pancreatic cancer	3.48e-05	0.00011	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.46e-05	0.00011	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AKT1—pancreatic cancer	3.45e-05	0.000109	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.45e-05	0.000109	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—APOE—pancreatic cancer	3.44e-05	0.000109	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—APOE—pancreatic cancer	3.43e-05	0.000109	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KDR—pancreatic cancer	3.42e-05	0.000109	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—pancreatic cancer	3.42e-05	0.000108	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.37e-05	0.000107	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KDR—pancreatic cancer	3.37e-05	0.000107	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KDR—pancreatic cancer	3.36e-05	0.000107	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CCND1—pancreatic cancer	3.33e-05	0.000106	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.3e-05	0.000105	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CTNNB1—pancreatic cancer	3.29e-05	0.000105	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—pancreatic cancer	3.27e-05	0.000104	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—PIK3CA—pancreatic cancer	3.26e-05	0.000103	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	3.25e-05	0.000103	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—pancreatic cancer	3.25e-05	0.000103	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MMP9—pancreatic cancer	3.23e-05	0.000102	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	3.22e-05	0.000102	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PTEN—pancreatic cancer	3.21e-05	0.000102	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NFKBIA—pancreatic cancer	3.2e-05	0.000102	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	3.19e-05	0.000101	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH1—pancreatic cancer	3.17e-05	0.000101	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	3.16e-05	0.0001	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CB—pancreatic cancer	3.16e-05	0.0001	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CD—pancreatic cancer	3.15e-05	0.0001	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	3.15e-05	0.0001	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	3.15e-05	0.0001	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.14e-05	9.97e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CD—pancreatic cancer	3.14e-05	9.96e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKT1—pancreatic cancer	3.13e-05	9.94e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.12e-05	9.92e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGF—pancreatic cancer	3.11e-05	9.88e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3.11e-05	9.88e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.11e-05	9.87e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CG—pancreatic cancer	3.1e-05	9.84e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—NRAS—pancreatic cancer	3.1e-05	9.84e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	3.09e-05	9.82e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	3.09e-05	9.82e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—KRAS—pancreatic cancer	3.09e-05	9.8e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—KRAS—pancreatic cancer	3.07e-05	9.75e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGF—pancreatic cancer	3.06e-05	9.72e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGF—pancreatic cancer	3.06e-05	9.7e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	3.04e-05	9.66e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	3.04e-05	9.66e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CXCL8—pancreatic cancer	3.03e-05	9.62e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—HRAS—pancreatic cancer	3.01e-05	9.56e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	3.01e-05	9.55e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.99e-05	9.5e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—SRC—pancreatic cancer	2.98e-05	9.45e-05	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKT1—pancreatic cancer	2.93e-05	9.29e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—pancreatic cancer	2.9e-05	9.21e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—VEGFA—pancreatic cancer	2.9e-05	9.2e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—STAT3—pancreatic cancer	2.87e-05	9.11e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	2.87e-05	9.11e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NRAS—pancreatic cancer	2.86e-05	9.09e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.84e-05	9e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CCND1—pancreatic cancer	2.82e-05	8.96e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—pancreatic cancer	2.82e-05	8.96e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—PIK3CA—pancreatic cancer	2.82e-05	8.96e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	2.82e-05	8.94e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CTNNB1—pancreatic cancer	2.8e-05	8.88e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	2.77e-05	8.8e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	2.77e-05	8.79e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CB—pancreatic cancer	2.75e-05	8.73e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.74e-05	8.71e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MMP9—pancreatic cancer	2.74e-05	8.7e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CB—pancreatic cancer	2.74e-05	8.68e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PTEN—pancreatic cancer	2.73e-05	8.65e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CD—pancreatic cancer	2.73e-05	8.65e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	2.72e-05	8.63e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	2.71e-05	8.61e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.7e-05	8.57e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.69e-05	8.55e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	2.68e-05	8.49e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—KRAS—pancreatic cancer	2.67e-05	8.47e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MYC—pancreatic cancer	2.67e-05	8.47e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	2.66e-05	8.45e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TGFB1—pancreatic cancer	2.66e-05	8.44e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKT1—pancreatic cancer	2.66e-05	8.44e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.65e-05	8.41e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CXCL8—pancreatic cancer	2.64e-05	8.39e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CXCL8—pancreatic cancer	2.63e-05	8.34e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—HRAS—pancreatic cancer	2.63e-05	8.33e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	2.62e-05	8.31e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—HRAS—pancreatic cancer	2.61e-05	8.29e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—pancreatic cancer	2.61e-05	8.28e-05	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKT1—pancreatic cancer	2.55e-05	8.1e-05	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKT1—pancreatic cancer	2.54e-05	8.06e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—pancreatic cancer	2.53e-05	8.03e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—SRC—pancreatic cancer	2.53e-05	8.02e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—pancreatic cancer	2.52e-05	7.98e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.49e-05	7.91e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—KRAS—pancreatic cancer	2.46e-05	7.82e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—VEGFA—pancreatic cancer	2.46e-05	7.81e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CCND1—pancreatic cancer	2.46e-05	7.81e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—PIK3CA—pancreatic cancer	2.45e-05	7.78e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CCND1—pancreatic cancer	2.45e-05	7.77e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.45e-05	7.76e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—STAT3—pancreatic cancer	2.44e-05	7.74e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CTNNB1—pancreatic cancer	2.44e-05	7.74e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—APOE—pancreatic cancer	2.44e-05	7.73e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NRAS—pancreatic cancer	2.43e-05	7.72e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CTNNB1—pancreatic cancer	2.43e-05	7.7e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	2.41e-05	7.66e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.41e-05	7.64e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MMP9—pancreatic cancer	2.39e-05	7.58e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MMP9—pancreatic cancer	2.38e-05	7.55e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PTEN—pancreatic cancer	2.38e-05	7.54e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CB—pancreatic cancer	2.38e-05	7.54e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	2.37e-05	7.52e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	2.36e-05	7.5e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.33e-05	7.4e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	2.32e-05	7.36e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	2.32e-05	7.36e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	2.31e-05	7.32e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	2.31e-05	7.31e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	2.28e-05	7.24e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	2.28e-05	7.23e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	2.27e-05	7.2e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MYC—pancreatic cancer	2.27e-05	7.19e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—PIK3CA—pancreatic cancer	2.26e-05	7.19e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	2.26e-05	7.18e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TGFB1—pancreatic cancer	2.26e-05	7.17e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.24e-05	7.11e-05	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	2.24e-05	7.11e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.23e-05	7.07e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	2.22e-05	7.05e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—pancreatic cancer	2.22e-05	7.03e-05	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	2.21e-05	7e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	2.2e-05	6.99e-05	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	2.2e-05	6.98e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.2e-05	6.98e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	2.19e-05	6.96e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—pancreatic cancer	2.19e-05	6.95e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	2.18e-05	6.93e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	2.18e-05	6.92e-05	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.17e-05	6.87e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	2.16e-05	6.86e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	2.15e-05	6.81e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.15e-05	6.81e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	2.14e-05	6.79e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	2.14e-05	6.78e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	2.13e-05	6.75e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	2.13e-05	6.74e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	2.12e-05	6.73e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.12e-05	6.73e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	2.12e-05	6.73e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	2.11e-05	6.71e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	2.11e-05	6.69e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	2.11e-05	6.68e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	2.1e-05	6.67e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	2.1e-05	6.66e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HRAS—pancreatic cancer	2.1e-05	6.65e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—KRAS—pancreatic cancer	2.09e-05	6.64e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.09e-05	6.63e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	2.09e-05	6.62e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.07e-05	6.56e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	2.06e-05	6.55e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	2.06e-05	6.54e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	2.05e-05	6.51e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	2.05e-05	6.5e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	2.04e-05	6.46e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.03e-05	6.43e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.02e-05	6.4e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	2e-05	6.36e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	2e-05	6.34e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	1.97e-05	6.27e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	1.97e-05	6.25e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.97e-05	6.24e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	1.96e-05	6.23e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	1.96e-05	6.22e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—SRC—pancreatic cancer	1.93e-05	6.14e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.93e-05	6.13e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	1.93e-05	6.13e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—PIK3CA—pancreatic cancer	1.92e-05	6.1e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	1.92e-05	6.1e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	1.9e-05	6.04e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.9e-05	6.03e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	1.88e-05	5.98e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.87e-05	5.93e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	1.87e-05	5.92e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	1.86e-05	5.91e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—pancreatic cancer	1.86e-05	5.9e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	1.85e-05	5.88e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	1.85e-05	5.87e-05	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKT1—pancreatic cancer	1.85e-05	5.87e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	1.84e-05	5.83e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	1.83e-05	5.81e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	1.83e-05	5.81e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	1.83e-05	5.8e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	1.82e-05	5.79e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.82e-05	5.78e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	1.82e-05	5.76e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.8e-05	5.72e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.8e-05	5.71e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HRAS—pancreatic cancer	1.78e-05	5.65e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MYC—pancreatic cancer	1.73e-05	5.5e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	1.73e-05	5.49e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	1.71e-05	5.41e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MYC—pancreatic cancer	1.7e-05	5.4e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	1.7e-05	5.4e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	1.7e-05	5.39e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	1.7e-05	5.38e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.68e-05	5.34e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.68e-05	5.32e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.67e-05	5.32e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.67e-05	5.3e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.67e-05	5.3e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	1.67e-05	5.3e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	1.67e-05	5.29e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	1.66e-05	5.28e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.64e-05	5.2e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	1.62e-05	5.15e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	1.61e-05	5.12e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	1.6e-05	5.08e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	1.58e-05	5e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	1.57e-05	4.99e-05	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKT1—pancreatic cancer	1.57e-05	4.99e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	1.55e-05	4.92e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.55e-05	4.91e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	1.54e-05	4.9e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	1.47e-05	4.67e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.46e-05	4.62e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	1.45e-05	4.6e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	1.45e-05	4.59e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—pancreatic cancer	1.42e-05	4.52e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.42e-05	4.51e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	1.4e-05	4.45e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—pancreatic cancer	1.4e-05	4.44e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.38e-05	4.37e-05	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	1.37e-05	4.35e-05	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	1.36e-05	4.32e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	1.36e-05	4.32e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	1.34e-05	4.25e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	1.34e-05	4.24e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.32e-05	4.17e-05	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.2e-05	3.82e-05	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.18e-05	3.75e-05	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.18e-05	3.75e-05	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.16e-05	3.69e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.03e-05	3.26e-05	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.39e-06	2.66e-05	CbGpPWpGaD
